WALTHAM, Mass.--(BUSINESS WIRE)--N-of-One, Inc., a leading provider of molecular interpretation and therapeutic strategies for personalized cancer care, today announced that the company has been named to BostInno’s first-ever 50 on Fire list, recognizing the city’s leading innovators, disrupters, luminaries, and newsmakers across multiple industries in Boston. N-of-One was ranked among the top healthcare and medicine companies in recognition of its growth, innovation and contribution.
N-of-One, an innovator in personalized medicine, provides oncologists and their patients with the latest and most comprehensive clinical knowledge available regarding the molecular characteristics of each patient’s tumor. The company is a leader in translating molecular data into clinical insights to support oncologists with additional treatment options for each of their patients.
"The team at N-of-One is very excited to be recognized by BostInno as one of the city’s best healthcare and medicine companies,” said Jennifer Levin Carter MD MPH, founder and Chief Medical Officer of N-of-One. “This award highlights the importance of N-of-One’s contribution to helping physicians and oncologists deliver personalized medicine in cancer care on a broadening scale.”
50 on Fire finalists were selected based on a list of criteria developed by the BostInno team, including growth, innovation and contributions to the Boston community. Inclusion on the list is based on the expertise of anonymous judges as well as BostInno’s community of readers. BostInno received more than 2,000 50 on Fire nominations across nine categories.
About N-of-One
N-of-One, a leader in precision medicine, leverages its world-class team of experts to translate molecular data specific to each patient into state-of-the-art, clinically actionable insights and therapeutic options focused on the point of care. Using the company's PrecisionWorks knowledge integration platform and framework, N-of-One's team of experts has delivered thousands of personalized, interpretative reports to oncologists and patients worldwide either directly, through agreements with provider networks (such as Fox Chase Cancer Center in Philadelphia) or through partnerships to provide interpretation services for leading diagnostic companies (such as Foundation Medicine and Clarient).
N-of-One solutions and services can incorporate data from any sequencing platform, diagnostic or bioinformatics system. PrecisionWorks also powers solutions that address the unique logistical and procedural challenges of delivering personalized cancer care by streamlining coordination among health care providers, diagnostic companies, drug and technology innovators and payers. N-of-One does not provide medical advice or promote any product or service. For more information, please visit www.n-of-one.com or call 617-202-9808.
About BostInno
BostInno, a Streetwise Media Property, is reinventing Boston news. BostInno’s fast-paced team of writers covers local innovation in tech, startups, business, finance, higher education, and city life with an unparalleled edge. For more on BostInno, visit http://bostinno.com/.
About 50 on Fire
BostInno's 50 on Fire is an awards event like no other, recognizing Boston's inventors, disrupters, innovators, luminaries, game-changers, and newsmakers across all industries. The March 26th event celebrates the city's hottest individuals and organizations in spectacular fashion, by bringing everyone under one roof for an evening of fine food, drink, and celebration, honoring those setting the Boston scene on fire.